UHealth - University of Miami Health System

E-mail a Friend

Alessia Fornoni, M.D., Ph.D.

General Information

Alessia  Fornoni, M.D., Ph.D.


  • Fax: 305-243-4404


  • Nephrology - Internal Medicine
  • Internal Medicine


English, Italian

Clinical Areas

Diabetic nephropathy, glomerular diseases, inherited nephropathies, chronic kidney disease


  • American Board of Internal Med-Nephrology


  • Director Katz family Drug Discovery Center
  • Professor of Medicine

Research Interests

Podocytes and mechanisms of proteinuria

nephrotic syndrome

Diabetes and diabetic complications

lipid biology and insulin signlaing

drug developement

target identification




Scientific Award Committee
Scientific Award Committee
Professional Development Course, American Society of Nephrology
Stanley Glaser Award
Amgen junior faculty award
Stanley J. Glaser Foundation Biomedical Research Award
Professional development seminar award


2000 Ph.D.
Universita' degli Studi di Pavia
1995 M.D.
Universita' degli Studi di Pavia


Dr Fornoni obtained her MD and her PhD degree in Medical Pharmacology at the Universita' degli Studi di Pavia (Italy). She later joined the laboratory of Renal Cell Biology (Vascular Biology Institute) at the University of Miami, where she worked on animal models of diabetic nephropathy and on the role of mesangial stem cells progenitors under the direct supervision of Drs Liliane and Gary Striker. After her post-doctoral fellowship, Dr Fornoni completed the Internal Medicine and Nephrology training at the University of Miami (Basic Scientist Investigator pathway). She is Board Certified in both Internal Medicine and Nephrology. She currently devotes 75% of her time to research and 25% to patient care. Dr Fornoni research interest is focus on proteinuria and kidney diseases, with particular interest in diabetic nephropathy and focal and segmental gloemrulosclerosis. Dr Fornoni is currently interested in the intracellular signaling pathways modulated by intracellular lipids. Dr. Fornoni research goal is to translate her basic science findings into clinical research through the identification of new therapeutic targets for chronic kidney disease.


E-mail a Friend